Profile data is unavailable for this security.
About the company
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
- Revenue in EUR (TTM)596.63m
- Net income in EUR17.00m
- Incorporated1986
- Employees2.10k
- LocationIon Beam Applications SAChemin du Cyclotron 3LOUVAIN-LA-NEUVE 1348BelgiumBEL
- Phone+32 10475811
- Fax+32 10475810
- Websitehttps://iba-worldwide.com
More ▼
Mergers & acquisitions
| Acquired company | IBAB:BRU since announced | Transaction value |
|---|---|---|
| Optimized Radiochemical Applications | 28.00% | -- |
Data delayed at least 15 minutes, as of Feb 12 2026 16:35 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stratec SE | 256.91m | 15.65m | 248.63m | 1.42k | 15.88 | 1.04 | 7.21 | 0.9678 | 1.29 | 1.29 | 21.13 | 19.75 | 0.5825 | 1.32 | 5.65 | 177,177.20 | 3.55 | 6.72 | 4.24 | 7.96 | 29.09 | 28.41 | 6.09 | 9.63 | 1.65 | 6.85 | 0.3552 | 37.35 | -4.73 | 3.76 | 4.24 | 2.35 | -7.49 | -6.51 |
| CellaVision AB | 71.84m | 14.49m | 340.89m | 236.00 | 23.53 | 4.06 | 18.72 | 4.75 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
| Medistim ASA | 59.39m | 12.65m | 350.21m | 154.00 | 27.60 | 9.39 | 23.33 | 5.90 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| COLTENE Holding AG | 262.76m | 15.63m | 354.20m | 1.18k | 22.67 | 3.59 | 15.40 | 1.35 | 2.40 | 2.40 | 40.22 | 15.13 | 1.31 | 1.34 | 6.40 | 204,684.50 | 7.80 | 10.59 | 14.26 | 18.43 | 66.11 | 62.19 | 5.95 | 7.64 | 0.7043 | 7.62 | 0.3606 | 85.66 | 3.06 | -1.79 | 71.31 | 0.4306 | -15.45 | 10.76 |
| IVF Hartmann Holding AG | 174.05m | 20.76m | 378.57m | 309.00 | 18.25 | 2.39 | 14.33 | 2.18 | 7.92 | 7.92 | 66.39 | 60.57 | 0.8964 | 3.28 | 7.88 | 526,221.10 | 10.69 | 7.90 | 12.91 | 9.68 | 55.71 | 54.06 | 11.93 | 9.13 | 3.79 | -- | 0.0042 | 48.54 | 7.33 | 2.85 | 34.02 | 10.78 | -28.94 | 19.92 |
| Ion Beam Applications SA | 596.63m | 17.00m | 460.29m | 2.10k | 26.77 | 3.75 | 15.62 | 0.7715 | 0.5677 | 0.5677 | 20.17 | 4.06 | 0.9756 | 2.73 | 3.28 | 281,693.60 | 2.78 | 1.50 | 12.03 | 4.64 | 31.21 | 34.39 | 2.85 | 2.15 | 0.6209 | 7.41 | 0.3631 | 70.81 | 6.75 | 12.01 | 201.57 | 3.99 | 7.69 | 25.86 |
| Revenio Group Oyj | 109.70m | 17.40m | 480.79m | 247.00 | 27.55 | 4.18 | 22.05 | 4.38 | 0.654 | 0.654 | 4.12 | 4.31 | 0.7515 | 3.05 | 7.26 | 444,129.60 | 11.92 | 14.00 | 14.23 | 17.40 | 70.92 | 70.95 | 15.86 | 19.38 | 1.63 | 9.66 | 0.0969 | -- | 5.97 | 12.43 | -5.93 | 5.42 | 22.19 | -- |
| Lumibird SA | 215.95m | 10.73m | 510.00m | 1.07k | 47.54 | 2.55 | 16.76 | 2.36 | 0.4775 | 0.4775 | 9.61 | 8.90 | 0.5077 | 0.9593 | 4.42 | 202,198.50 | 2.52 | 2.51 | 3.11 | 3.17 | 63.89 | 61.89 | 4.97 | 4.90 | 1.64 | 3.16 | 0.4583 | 0.00 | 1.75 | 13.34 | -20.08 | -8.38 | 15.27 | -- |
| RaySearch Laboratories AB (publ) | 122.24m | 20.74m | 511.32m | 450.00 | 27.43 | 6.54 | 11.16 | 4.18 | 6.39 | 6.39 | 37.69 | 26.82 | 0.6523 | 4.15 | 2.84 | 3,104,637.00 | 11.07 | 2.96 | 16.31 | 4.37 | 92.96 | 90.93 | 16.97 | 5.80 | 1.55 | -- | 0.309 | 67.90 | 16.62 | 9.96 | 149.49 | 32.19 | 0.5132 | -- |
| medmix AG | 510.98m | -6.33m | 535.10m | 2.67k | -- | 1.14 | 10.07 | 1.05 | -0.1696 | -0.1696 | 11.60 | 10.39 | 0.4707 | 3.56 | 5.86 | 174,403.90 | -0.4927 | 1.27 | -0.6199 | 1.55 | 34.52 | 35.24 | -1.05 | 2.65 | 1.10 | 1.87 | 0.4268 | 140.79 | -0.5549 | 2.84 | -2,566.67 | -- | 6.02 | -- |
| Xvivo Perfusion AB | 76.87m | 2.38m | 537.25m | 198.00 | 226.17 | 2.69 | 59.52 | 6.99 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Advanced Medical Solutions Group plc | 252.91m | 10.47m | 544.51m | 1.50k | 51.81 | 1.85 | 15.60 | 2.15 | 0.0417 | 0.0417 | 1.01 | 1.17 | 0.5758 | 2.09 | 5.57 | 137,690.00 | 2.38 | 5.09 | 2.63 | 5.52 | 52.19 | 55.06 | 4.14 | 11.15 | 1.55 | 3.88 | 0.2428 | 33.47 | 40.66 | 11.64 | -55.35 | -17.81 | 8.36 | 10.90 |
| Synektik SA | 125.03m | 22.44m | 607.40m | 203.00 | 27.06 | 11.49 | 24.01 | 4.86 | 11.09 | 9.20 | 61.80 | 26.12 | 1.22 | 11.18 | 3.60 | -- | 21.96 | 20.11 | 36.10 | 32.67 | 34.98 | 31.40 | 17.95 | 13.60 | 1.41 | 42.09 | 0.153 | -- | 9.16 | 40.29 | 51.58 | 70.02 | 28.82 | -- |
| Gerresheimer AG | 2.25bn | 23.35m | 644.86m | 13.54k | 27.62 | 0.46 | 2.31 | 0.2866 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Arjo AB (publ) | 1.04bn | 31.61m | 650.94m | 6.94k | 22.07 | 0.9884 | 4.82 | 0.6252 | 1.23 | 1.23 | 40.39 | 27.38 | 0.704 | 4.92 | 6.22 | 1,584,702.00 | 2.14 | 3.26 | 2.91 | 4.80 | 42.59 | 43.42 | 3.04 | 4.78 | 0.8494 | 4.19 | 0.4179 | 48.74 | -2.59 | 3.92 | -32.93 | -8.68 | -- | 2.25 |
Data as of Feb 12 2026. Currency figures normalised to Ion Beam Applications SA's reporting currency: Euro EUR
19.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Premier Fund Managers Ltd.as of 30 Sep 2025 | 1.82m | 6.00% |
| Van Lanschot Kempen Investment Management NVas of 31 Dec 2024 | 875.39k | 2.89% |
| Belfius Insurance SA NVas of 28 Apr 2025 | 839.57k | 2.77% |
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 31 Dec 2024 | 768.77k | 2.54% |
| NS Partners Europe SAas of 31 Dec 2024 | 405.36k | 1.34% |
| Investor Asset Management BVas of 30 Jan 2026 | 315.00k | 1.04% |
| BNP Paribas Asset Management Belgium SAas of 31 Dec 2025 | 305.42k | 1.01% |
| Econopolis Wealth Management NVas of 31 Dec 2024 | 270.00k | 0.89% |
| BNP Paribas Asset Management Europe SASas of 30 Jun 2025 | 173.58k | 0.57% |
| Niche Asset Management Ltd.as of 30 Jun 2025 | 170.24k | 0.56% |
More ▼
Data from 31 Dec 2024 - 05 Feb 2026Source: FactSet Research Systems Inc.
